BNGO - Bngo Stock Rises as Optical Genome Mapping Is Better at Detecting Mutations
BNGO stock closed Tuesday trading at $2.0400 at close: 04:00 PM EDT
On October 4, Bionano Genomics ( NASDAQ:BNGO ) reported that a study found that whole genome sequencing (WGS) only identified 63% of structural alterations discovered by optical genome mapping (OGM) in liver cancer.
The research, conducted by a team from Sorbonne University and published in the journal Cancer Research, demonstrated the use of OGM to examine complex structural variations (SVs) brought on by replication stress in a molecular subgroup of hepatocellular carcinoma (HCC), the company stated in a press release on October 4.
According to Bionano ( NASDAQ:BNGO ), the study employed an OGM and WGS process to analyze complicated rearrangements and resolve them at base pair resolution, as well as to maximize the discovery of pathogenic and potentially pathogenic variants.
Imagine Your ROI If You Invested $1,000 In Bionano (Bngo) Stock At Its COVID-19 Pandemic Low.
Researchers were able to compare OGM and WGS utilizing the methodology, and they found that just 63% of SVs identified by OGM were also identified by WGS, according to the business.
According to the business, OGM showed a median of 1.4 times more SVs than WGS.
According to Erik Holmlin, president and chief executive officer of Bionano, “It demonstrates that OGM can be more s...
Click here to read the full article on PressReach.com .Subscribe to the PressReach RSS feeds:
- Featured News RSS feed
- Investing News RSS feed
- Daily Press Releases RSS feed
- Trading Tips RSS feed
- Investing Videos RSS feed
Follow PressReach on Twitter
Subscribe to us on Youtube
PressReach Disclaimer .